Most Helpful

"Cerberus Capital Management is, in part, a private equity firm. That means it often buys companies, controls them, and then sells them.

  • This rudimentary description might seem obvious to you, but apparently not to Cerberus.

Behind the scenes: Cerberus took issue with what I wrote on Wednesday about Steward Health, the hospital chain that it owned between 2010 and 2020.

  • Not the part about how Steward is struggling under the weight of liabilities accrued under Cerberus' watch, nor how those transactions resulted in hundreds of millions of dollars in profit for Cerberus and its investors.
  • Instead, Cerberus disagreed with my characterization of Cerberus being in charge of Steward in the first place. Really.

Two things I wrote: "In 2014, Cerberus closed one of the Mass. hospitals it had acquired, despite having pledged not to do so for at least 10 years after the acquisition, as part of the state regulatory approval process."

  • Also: "Cerberus, which threatened to shut a small Pennsylvania hospital early in the pandemic..."

How Cerberus replied, via a spokesperson:

"Neither of these statements are true. It is inaccurate to attribute either of these actions to Cerberus. Steward made its operating decisions. Cerberus did not have a majority of seats on the Board.  And, at the risk of stating the obvious, Steward and Cerberus are separate companies."

Between the lines: First, Cerberus did indeed have a majority of seats on Steward's board, according to cached versions of the company's own website and public disclosures.

  • There isn't one publicly available for 2014, but I did find them for 2010, 2012, 2019 and 2020. In each of them, Cerberus had numerical board control. In fact, that's one reason these sorts of deals are sometimes referred to as control investments.
  • I asked Cerberus on Wednesday night for details of the 2014 board composition, but so far they've not provided it. Which is weird, since they seemed so sure in the original email.
  • Then there's the operating decisions, of which Cerberus is trying to wash its hands. Perhaps it should check the section on its own website titled "Operational Private Equity," in which Cerberus extols its efforts to "identify and execute key operating initiatives" at portfolio companies.
  • Yes it's true that Cerberus and Steward are separate companies, but Steward was not independent of Cerberus. Instead, it was structurally subordinate to Cerberus. At the barest minimum, Cerberus would have learned about hospital closure plans after they were announced, and could have reversed them.

The bottom line: It isn't unusual for companies or investment firms to complain about something written here. But Cerberus might win the prize for unintentional comedy."

 

"The obedient always think of themselves as virtuous rather than cowardly" - Robert A. Wilson | "If you don't have any enemies in life you have never stood up for anything" - Winston Churchill | "It's a testament to the sheer belligerence of the profession that people would rather argue about the 'risk-adjusted returns' of using inferior tooth cleaning methods." - kellycriterion
 

As much I disagree with FTC on their antitrust litigations, especially Lina Khan's view on antitrust enforcement, I would say the investigation she is doing into Healthcare PE is a good thing, too many issues with hospitals/clinics run by PE

 

Certain practices sure - PE-run staffing companies and hospital in general are close to as pure evil as you can get in healthcare. General Catalyst / Summa is probably an exception since it's more of a growth / tech play. Straight up buyouts? Definitely a lot of shady stuff going on there.

 

Eh I don't think outpatient services is as badly run as PE-backed in-patient / hospital facilities. Used to work at one pre-MBA and it was honestly really fun to work there. If it was still privately owned and in the growth phase, I would have 100% returned back post MBA as long as I got to join the corporate team I want.

Will agree though on HCIT / Pharma spaces being very interesting. Familiar with HCIT, not so much pharma (CROs etc).

 

Qui labore dicta consequatur neque qui. Sequi quidem quasi quia est omnis ipsam amet. Quibusdam quis reprehenderit minus debitis nihil. Harum perspiciatis ipsam consequuntur et totam. Quis dolore aut autem et voluptatem.

Id in sint cum nihil et. Eius dolor iusto nobis odit placeat.

 

Voluptatem qui laudantium quidem maxime veritatis. Nihil quaerat aut occaecati iusto vero dolore. Ratione qui nihil fuga perspiciatis aut quas quos. Assumenda corporis nostrum ut aperiam velit quia.

Non tenetur eos qui at inventore enim. Laudantium reiciendis assumenda aut. Sunt et quidem et. Quod dolor tenetur ullam qui.

Temporibus nihil est non quis quisquam laudantium consequuntur aut. Saepe atque voluptate voluptatem harum eligendi minima aut. Quasi sed id iure totam et. Sunt suscipit sit consequuntur ut nostrum dignissimos.

Voluptatem id eaque natus sint. Eos alias iste et nulla. Laudantium aperiam numquam quaerat repudiandae sint. Et et eum nesciunt explicabo rerum. Quos nostrum reiciendis ipsum sequi.

Career Advancement Opportunities

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 99.0%
  • Warburg Pincus 98.4%
  • KKR (Kohlberg Kravis Roberts) 97.9%
  • Bain Capital 97.4%

Overall Employee Satisfaction

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 98.9%
  • KKR (Kohlberg Kravis Roberts) 98.4%
  • Ardian 97.9%
  • Bain Capital 97.4%

Professional Growth Opportunities

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Bain Capital 99.0%
  • Blackstone Group 98.4%
  • Warburg Pincus 97.9%
  • Starwood Capital Group 97.4%

Total Avg Compensation

May 2024 Private Equity

  • Principal (9) $653
  • Director/MD (22) $569
  • Vice President (92) $362
  • 3rd+ Year Associate (91) $281
  • 2nd Year Associate (206) $268
  • 1st Year Associate (389) $229
  • 3rd+ Year Analyst (29) $154
  • 2nd Year Analyst (83) $134
  • 1st Year Analyst (246) $122
  • Intern/Summer Associate (32) $82
  • Intern/Summer Analyst (316) $59
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
kanon's picture
kanon
98.9
9
Kenny_Powers_CFA's picture
Kenny_Powers_CFA
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”